30 results
8-K
EX-10.1
UNCY
Unicycive Therapeutics Inc
14 Mar 24
Unicycive Announces $50 Million Private Placement
4:28pm
to so pay or file any such tax, assessment, charge or return would not have or reasonably be expected to result in a Material Adverse Effect
8-K
EX-99.1
pp3n70 xxca8qa
29 Jun 23
Unicycive Therapeutics Provides Regulatory Update on Lanthanum Dioxycarbonate Program
5:50pm
8-K
EX-99.1
hs3qp6bbntft4l7fyb3k
14 Nov 22
Unicycive Announces Third Quarter Financial Results and Provides Business Update
9:49am
S-3
EX-4.4
ub2epapf3me rju
15 Aug 22
Shelf registration
6:20pm
S-3
EX-4.3
xoch jfxlg58ciza
15 Aug 22
Shelf registration
6:20pm
S-3
EX-1.1
fy811lptzda9tf4jl3q
15 Aug 22
Shelf registration
6:20pm
10-K
jntxp w48azr3xs3i6b
31 Mar 22
Annual report
6:18am
10-Q
ixo2m4htv 2j8
16 Aug 21
Quarterly report
6:06am
424B4
xwjldo76uh
14 Jul 21
Prospectus supplement with pricing info
1:59pm